Aortic valve stenosis is the most common valve disease in the western world. Over the past few years the number of aortic valve replacement （AVR） interventions has increased with outcomes that have been improved des...Aortic valve stenosis is the most common valve disease in the western world. Over the past few years the number of aortic valve replacement （AVR） interventions has increased with outcomes that have been improved despite increasing age of patients and increasing bur- den of comorbidities. However, despite such excellent results and its well-established position, conventional AVR has undergone great de- velopment over the previous two decades. Such progress, by way of less irtvasive incisions and use of new technologies, including tran- scatheter aortic valve implantation and sutureless valve prostheses, is intended to reduce the traumatic impact of the surgical procedure, thus fulfilling lower risk patients＇ expectations on the one hand, and extending the operability toward increasingly high-risk patients on the other. Sutureless and rapid deployment aortic valves are biological, pericardial prostheses that anchor within the aortic annulus with no more than three sutures. The sutureless prostheses, by avoiding the passage and the tying of the sutures, significantly reduce operative times and may improve outcomes. However, there is still a paucity of robust, evidence-based data on the role and performance of sutureless AVR. Therefore, strongest long-term data, randomized studies and registry data are required to adequately assess the durability and long-term outcomes of sutureless aortic valve replacement.展开更多
文摘Aortic valve stenosis is the most common valve disease in the western world. Over the past few years the number of aortic valve replacement （AVR） interventions has increased with outcomes that have been improved despite increasing age of patients and increasing bur- den of comorbidities. However, despite such excellent results and its well-established position, conventional AVR has undergone great de- velopment over the previous two decades. Such progress, by way of less irtvasive incisions and use of new technologies, including tran- scatheter aortic valve implantation and sutureless valve prostheses, is intended to reduce the traumatic impact of the surgical procedure, thus fulfilling lower risk patients＇ expectations on the one hand, and extending the operability toward increasingly high-risk patients on the other. Sutureless and rapid deployment aortic valves are biological, pericardial prostheses that anchor within the aortic annulus with no more than three sutures. The sutureless prostheses, by avoiding the passage and the tying of the sutures, significantly reduce operative times and may improve outcomes. However, there is still a paucity of robust, evidence-based data on the role and performance of sutureless AVR. Therefore, strongest long-term data, randomized studies and registry data are required to adequately assess the durability and long-term outcomes of sutureless aortic valve replacement.
